Hongyuan Pharmaceutical: List of first-time incentive recipients granted under the 2025 Restricted Stock Incentive Plan (as of the date of grant)
Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
List of first-time incentive recipients granted under the 2025 Restricted Stock Incentive Plan (as of the date of grant)
1. Allocation of restricted stocks granted to incentive targets
Restrictions on the award. Restrictions on the award. Restrictions on the award. Public order at the time of the award.
Name Nationality Position Number of shares Total number of shares Ratio of total share capital of the company
Ratio of (10,000 shares) Example 1 Deng Zhihua China Director and Deputy General Manager 8.00 1.72% 0.02% 2 Liao Shengru China Deputy General Manager 8.00 1.72% 0.02% 3 Cheng Siyuan China Director and Deputy General Manager 6.00 1.29% 0.01%
Secretary of the Board of Directors, General Manager
4 Xiao Yonghua China 6.00 1.29% 0.01%
supervise
5 Zeng Kefeng China Financial Manager 6.00 1.29% 0.01% 6 Ding Wenbo China Director 8.50 1.83% 0.02% 7 Jia Xuefeng China Director 11.00 2.37% 0.03% 8 Shu Weifeng China Director 10.00 2.15% 0.02% 9 Dai Lina China Director 6.00 1.29% 0.01% 10 Ding Zhihua China Director 5.00 1.08% 0.01% Middle-level management personnel and core technology (business) backbones
296.75 63.95% 0.74% (303 people in total)
Reserved 92.8125 20.00% 0.23% Total 464.0625 100.00% 1.16%
Note: 1. The total number of underlying stocks involved in all the company's equity incentive plans within the validity period does not exceed 20% of the company's total share capital at the time of the announcement of the draft incentive plan. The cumulative number of shares of the company granted to any incentive target in this incentive plan through all equity incentive plans within the validity period does not exceed 1% of the company's total share capital at the time of the announcement of the draft incentive plan.
The intended incentive targets of this incentive plan do not include shareholders or actual controllers who individually or collectively hold more than 5% of the company's shares, their spouses, parents, children and foreign employees, and do not include the company's independent directors.
The reserved incentive objects will be determined within 12 months after the incentive plan is reviewed and approved by the shareholders' meeting. After the board of directors proposes, the remuneration and assessment committee issues clear opinions, and the lawyer expresses professional opinions and issues a legal opinion, the company will promptly and accurately disclose relevant information about the current incentive objects on the designated website as required.
If the total number of values in the above table does not match the sum of each sub-item value, it is due to rounding.
Board of Directors of Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
October 15, 2025